Mink Therapeutics | IPO Presentation Deck | 36 slides · page 36 of 36
The slide details two specific trial arms/phases for the AGENT-797 therapy.
Pitch deck · other · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 3/3
source-note 1/1 table 1/1 title 1/1
Components 3
source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.